662 Shares in Solventum Co. (NYSE:SOLV) Bought by Teachers Insurance & Annuity Association of America

Teachers Insurance & Annuity Association of America purchased a new position in shares of Solventum Co. (NYSE:SOLV) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 662 shares of the company’s stock, valued at approximately $46,000.

A number of other hedge funds have also bought and sold shares of the business. Price T Rowe Associates Inc. MD purchased a new stake in Solventum in the first quarter worth $5,889,000. CWM LLC purchased a new stake in Solventum in the second quarter worth $473,000. Great Valley Advisor Group Inc. purchased a new stake in Solventum in the second quarter worth $493,000. First Horizon Advisors Inc. purchased a new stake in Solventum in the second quarter worth $58,000. Finally, Swedbank AB purchased a new stake in Solventum in the second quarter worth $4,711,000.

Solventum Stock Up 1.4 %

Solventum stock traded up $0.99 during midday trading on Thursday, hitting $72.48. 702,921 shares of the company’s stock were exchanged, compared to its average volume of 1,695,591. Solventum Co. has a 52-week low of $47.16 and a 52-week high of $96.05. The stock has a 50-day moving average price of $70.51 and a two-hundred day moving average price of $62.47. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Morgan Stanley raised their target price on Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th. Piper Sandler lifted their price target on Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research report on Friday, November 8th. BTIG Research initiated coverage on Solventum in a research report on Thursday, September 5th. They issued a “neutral” rating for the company. Wells Fargo & Company reduced their price target on Solventum from $69.00 to $64.00 and set an “equal weight” rating for the company in a research report on Friday, August 9th. Finally, The Goldman Sachs Group lifted their price target on Solventum from $48.00 to $54.00 and gave the company a “sell” rating in a research report on Monday, August 12th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and one has issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $68.00.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.